GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Beijing Airdoc Technology Co Ltd (HKSE:02251) » Definitions » Notes Receivable

Beijing Airdoc Technology Co (HKSE:02251) Notes Receivable : HK$0.0 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Beijing Airdoc Technology Co Notes Receivable?

Beijing Airdoc Technology Co's Notes Receivable for the quarter that ended in Dec. 2023 was HK$0.0 Mil.


Beijing Airdoc Technology Co Notes Receivable Historical Data

The historical data trend for Beijing Airdoc Technology Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Airdoc Technology Co Notes Receivable Chart

Beijing Airdoc Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Notes Receivable
- - - - -

Beijing Airdoc Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Notes Receivable Get a 7-Day Free Trial Premium Member Only - - - - -

Beijing Airdoc Technology Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Beijing Airdoc Technology Co Notes Receivable Related Terms

Thank you for viewing the detailed overview of Beijing Airdoc Technology Co's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Airdoc Technology Co (HKSE:02251) Business Description

Traded in Other Exchanges
N/A
Address
West Third Ring North Road, Room 21, 4th Floor, Building 2, A2 Yard, Haidian District, Beijing, CHN
Beijing Airdoc Technology Co Ltd provides AI-empowered retina-based early detection, diagnosis and health risk assessment solutions in China. Leveraging retinal imaging, multimodal data analyses and AI deep learning algorithms, the company's solution differs from traditional chronic disease early detection and diagnosis, enabling non-invasive, accurate, fast, effective and scalable detection and diagnosis of chronic diseases in both medical institutions and consumer healthcare providers. The Company derives revenue principally from the provision of AI-based software solutions, sales of hardware devices and other services.
Executives
Mialkos Tomasz Jakub 2101 Beneficial owner
Zhang Dalei 2501 Other
Fosun Holdings Limited 2201 Interest of corporation controlled by you
Yadong Beichen Venture Investment Co., Ltd. 2101 Beneficial owner
Shanghai Ruikun Venture Capital Investment Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Fosun Industrial Investment Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd. 2201 Interest of corporation controlled by you
Guo Guangchang 2201 Interest of corporation controlled by you
Fosun International Limited 2201 Interest of corporation controlled by you
Fosun International Holdings Ltd. 2201 Interest of corporation controlled by you
Chen Mingqiang 2501 Other
Gao Fei 2501 Other
Niagara Falls Holding Limited 2101 Beneficial owner
China Life Franklin Asset Management Co., Limited
China Life Insurance (group) Company

Beijing Airdoc Technology Co (HKSE:02251) Headlines

No Headlines